Navigation Links
Isis Pharmaceuticals to Present a General Corporate Update at Its 2011 Annual Meeting of Stockholders and Open House
Date:5/23/2011

CARLSBAD, Calif., May 23, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a general corporate update in conjunction with its 2011 Annual Meeting of Stockholders and Open House on Thursday, June 16 at 2:15 p.m. Pacific Time in Carlsbad, CA.  The agenda for the meeting is as follows:2:00 p.m. – 2:15 p.m. Annual Meeting of Stockholders (only for stockholders of record as of April 20, 2011)2:15 p.m. – 3:00 p.m. Corporate Presentation – Stanley T. Crooke, Isis Chairman and Chief Executive Officer3:00 p.m. – 5:00 p.m. Poster PresentationA live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners.  The Company has successfully commercialized the world's first antisense drug and has 24 drugs in development.  Isis' drug development programs are focused on treating cardiovascular, metabolic, and severe neurodegenerative diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis has designed and executed a patent strategy that has provided the Company with strong and extensive protection for Isis' drugs and technology.  Additional information about Isis is available at www.isispharm.com.


'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting
2. Onyx Pharmaceuticals Announces Updated Pivotal Carfilzomib Phase 2B Data
3. Johnson & Johnson to Host Pharmaceuticals Business Review
4. Unilife to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
5. Ampio Pharmaceuticals, Inc. to Begin Trading on the NASDAQ Capital Market
6. Cempra Pharmaceuticals to Present at Two Investor Conferences in Paris
7. Onyx Pharmaceuticals Announces Data Presentations of Carfilzomib and ONX 0912 at 47th American Society of Clinical Oncology Annual Meeting
8. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
9. The Board of Directors of Kinex Pharmaceuticals Appoints Dr. David Hangauer as Chief Scientific Officer
10. Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market
11. Xanodyne Pharmaceuticals Appoints New Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... , March 1, 2017  The Welch Foundation, ... for basic research, today announced that Drs. Neal ... are the 2017 recipients of the Norman Hackerman ... recognized as ,rising stars, having contributed significant scientific discoveries ... first time in the 15 years of the Hackerman ...
(Date:3/1/2017)... , Mar 01, 2017 Research and ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... 2016, provides drug pricing data and benchmarks in the global Acute ... clinical attributes of your competitor drugs and find out how the ...
(Date:3/1/2017)... stesso sistema sara, visibile nello stand a ECR, il Congresso Europeo di Radiologia ... la settima unità MROpen in Gran Bretagna, la prima in Galles. Il sistema ... Cardiff. ESC attualmente gestisce altri due sistemi di risonanza magnetica MROpen a Londra ... ... The open MRI scanner - ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... ... After a long period of indulging in holidays, many individuals feel ready ... the detox categories, there is a rare yet successful way to cleanse the lungs ... Detox is an herbal-based formula designed to help cleanse people’s lungs from harmful chemicals ...
(Date:3/1/2017)... , ... March 01, 2017 , ... The Industrial Designers ... 5, 2017 by raising awareness of the profession of industrial design (ID) and relaunching ... content geared toward high school students and counselors; parents; and the greater public. , ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... the release of its 2017 update to Compass, the popular online learning ... advisors. , Suitable for standardizing both new-hire on-boarding and annual competency-validation, Compass ...
(Date:3/1/2017)... ... 2017 , ... Grund® America is proud to announce the new ... March 2017 International Housewares Show in Chicago (Grund Booth N6466). , “We are very ... quality,100% OEKO-TEX and GOTS Organic Cotton material. By adding the GOTS (Global Organic ...
(Date:3/1/2017)... ... March 01, 2017 , ... Granite ... colorectal cancer screening rates by supporting the 80% by 2018 initiative, led by ... and the National Colorectal Cancer Roundtable (an organization co-founded by ACS and CDC). ...
Breaking Medicine News(10 mins):